(8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine

C67H65ClF6N22O2 — CID 160574084

IUPAC(8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine
SMILESC1=C(c2cn[nH]c2)N2CCC[C@H]2CN1.FC(F)(F)c1cn2c(-c3nccc(Cl)n3)cnc2cn1.FC(F)(F)c1cn2c(-c3nccc(N4CC(c5cn[nH]c5)N5CCC[C@H]5C4)n3)cnc2cn1.O=C(OCc1ccccc1)N1C=C(c2cnn(Cc3ccccc3)c2)N2CCC[C@H]2C1
InChIInChI=1S/C25H26N4O2.C21H20F3N9.C11H5ClF3N5.C10H14N4/c30-25(31-19-21-10-5-2-6-11-21)27-17-23-12-7-13-29(23)24(18-27)22-14-26-28(16-22)15-20-8-3-1-4-9-20;22-21(23,24)17-12-33-15(8-27-19(33)9-26-17)20-25-4-3-18(30-20)31-10-14-2-1-5-32(14)16(11-31)13-6-28-29-7-13;12-8-1-2-16-10(19-8)6-3-18-9-4-17-7(5-20(6)9)11(13,14)15;1-2-9-6-11-7-10(14(9)3-1)8-4-12-13-5-8/h1-6,8-11,14,16,18,23H,7,12-13,15,17,19H2;3-4,6-9,12,14,16H,1-2,5,10-11H2,(H,28,29);1-5H;4-5,7,9,11H,1-3,6H2,(H,12,13)/t23-;14-,16?;;9-/m00.0/s1
InChIKeyRAXOTVILWIZLSB-BSFTUHFASA-N
MW1359.85 g/mol
LogP10.93
Rot. Bonds10

About (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine

(8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine (PubChem CID 160574084) has the molecular formula C67H65ClF6N22O2 and a molecular weight of 1359.85 g/mol. Its IUPAC name is (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine.

Molecular Properties

Compound Name(8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine
PubChem CID160574084
Molecular FormulaC67H65ClF6N22O2
Molecular Weight1359.85 g/mol
Exact Mass1358.53
IUPAC Name(8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine
SMILESC1=C(c2cn[nH]c2)N2CCC[C@H]2CN1.FC(F)(F)c1cn2c(-c3nccc(Cl)n3)cnc2cn1.FC(F)(F)c1cn2c(-c3nccc(N4CC(c5cn[nH]c5)N5CCC[C@H]5C4)n3)cnc2cn1.O=C(OCc1ccccc1)N1C=C(c2cnn(Cc3ccccc3)c2)N2CCC[C@H]2C1
InChIInChI=1S/C25H26N4O2.C21H20F3N9.C11H5ClF3N5.C10H14N4/c30-25(31-19-21-10-5-2-6-11-21)27-17-23-12-7-13-29(23)24(18-27)22-14-26-28(16-22)15-20-8-3-1-4-9-20;22-21(23,24)17-12-33-15(8-27-19(33)9-26-17)20-25-4-3-18(30-20)31-10-14-2-1-5-32(14)16(11-31)13-6-28-29-7-13;12-8-1-2-16-10(19-8)6-3-18-9-4-17-7(5-20(6)9)11(13,14)15;1-2-9-6-11-7-10(14(9)3-1)8-4-12-13-5-8/h1-6,8-11,14,16,18,23H,7,12-13,15,17,19H2;3-4,6-9,12,14,16H,1-2,5,10-11H2,(H,28,29);1-5H;4-5,7,9,11H,1-3,6H2,(H,12,13)/t23-;14-,16?;;9-/m00.0/s1
InChIKeyRAXOTVILWIZLSB-BSFTUHFASA-N
XLogP10.93
TPSA241.65 Ų
H-Bond Donors3
H-Bond Acceptors21
Rotatable Bonds10
Heavy Atoms98
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001359.85
LogP ≤ 510.93
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1021

Analyze (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine?
The IUPAC name of (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine (CID 160574084) is (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine.
What is the SMILES notation for (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine?
The canonical SMILES for (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine is C1=C(c2cn[nH]c2)N2CCC[C@H]2CN1.FC(F)(F)c1cn2c(-c3nccc(Cl)n3)cnc2cn1.FC(F)(F)c1cn2c(-c3nccc(N4CC(c5cn[nH]c5)N5CCC[C@H]5C4)n3)cnc2cn1.O=C(OCc1ccccc1)N1C=C(c2cnn(Cc3ccccc3)c2)N2CCC[C@H]2C1.
What is the InChIKey of (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine?
The InChIKey is RAXOTVILWIZLSB-BSFTUHFASA-N. The full InChI is InChI=1S/C25H26N4O2.C21H20F3N9.C11H5ClF3N5.C10H14N4/c30-25(31-19-21-10-5-2-6-11-21)27-17-23-12-7-13-29(23)24(18-27)22-14-26-28(16-22)15-20-8-3-1-4-9-20;22-21(23,24)17-12-33-15(8-27-19(33)9-26-17)20-25-4-3-18(30-20)31-10-14-2-1-5-32(14)16(11-31)13-6-28-29-7-13;12-8-1-2-16-10(19-8)6-3-18-9-4-17-7(5-20(6)9)11(13,14)15;1-2-9-6-11-7-10(14(9)3-1)8-4-12-13-5-8/h1-6,8-11,14,16,18,23H,7,12-13,15,17,19H2;3-4,6-9,12,14,16H,1-2,5,10-11H2,(H,28,29);1-5H;4-5,7,9,11H,1-3,6H2,(H,12,13)/t23-;14-,16?;;9-/m00.0/s1.
What are the key properties of (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine?
(8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine has a molecular weight of 1359.85 g/mol, XLogP of 10.93, 10 rotatable bonds, 3 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for (8aS)-4-(1H-pyrazol-4-yl)-1,2,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine;3-[4-[(8aS)-4-(1H-pyrazol-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;benzyl (8aS)-4-(1-benzylpyrazol-4-yl)-6,7,8,8a-tetrahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate;3-(4-chloropyrimidin-2-yl)-6-(trifluoromethyl)imidazo[1,2-a]pyrazine is sourced from PubChem (CID 160574084), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).